Cargando…

Overcoming sorafenib treatment-resistance in hepatocellular carcinoma: A future perspective at a time of rapidly changing treatment paradigms

Detalles Bibliográficos
Autores principales: Chen, Jiang, Duda, Dan G.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Elsevier 2020
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6997488/
https://www.ncbi.nlm.nih.gov/pubmed/32014823
http://dx.doi.org/10.1016/j.ebiom.2020.102644
_version_ 1783493709811154944
author Chen, Jiang
Duda, Dan G.
author_facet Chen, Jiang
Duda, Dan G.
author_sort Chen, Jiang
collection PubMed
description
format Online
Article
Text
id pubmed-6997488
institution National Center for Biotechnology Information
language English
publishDate 2020
publisher Elsevier
record_format MEDLINE/PubMed
spelling pubmed-69974882020-02-05 Overcoming sorafenib treatment-resistance in hepatocellular carcinoma: A future perspective at a time of rapidly changing treatment paradigms Chen, Jiang Duda, Dan G. EBioMedicine Commentary Elsevier 2020-01-31 /pmc/articles/PMC6997488/ /pubmed/32014823 http://dx.doi.org/10.1016/j.ebiom.2020.102644 Text en © 2020 The Author(s) http://creativecommons.org/licenses/by-nc-nd/4.0/ This is an open access article under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/).
spellingShingle Commentary
Chen, Jiang
Duda, Dan G.
Overcoming sorafenib treatment-resistance in hepatocellular carcinoma: A future perspective at a time of rapidly changing treatment paradigms
title Overcoming sorafenib treatment-resistance in hepatocellular carcinoma: A future perspective at a time of rapidly changing treatment paradigms
title_full Overcoming sorafenib treatment-resistance in hepatocellular carcinoma: A future perspective at a time of rapidly changing treatment paradigms
title_fullStr Overcoming sorafenib treatment-resistance in hepatocellular carcinoma: A future perspective at a time of rapidly changing treatment paradigms
title_full_unstemmed Overcoming sorafenib treatment-resistance in hepatocellular carcinoma: A future perspective at a time of rapidly changing treatment paradigms
title_short Overcoming sorafenib treatment-resistance in hepatocellular carcinoma: A future perspective at a time of rapidly changing treatment paradigms
title_sort overcoming sorafenib treatment-resistance in hepatocellular carcinoma: a future perspective at a time of rapidly changing treatment paradigms
topic Commentary
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6997488/
https://www.ncbi.nlm.nih.gov/pubmed/32014823
http://dx.doi.org/10.1016/j.ebiom.2020.102644
work_keys_str_mv AT chenjiang overcomingsorafenibtreatmentresistanceinhepatocellularcarcinomaafutureperspectiveatatimeofrapidlychangingtreatmentparadigms
AT dudadang overcomingsorafenibtreatmentresistanceinhepatocellularcarcinomaafutureperspectiveatatimeofrapidlychangingtreatmentparadigms